MET642

· Metacrine, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MET642, covering 2024-03-28 to 2024-03-28. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate MET642 in Patients With NASH [Phase 2]